|
Market Closed -
NSE India S.E.
07:05:10 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 573.20 INR | +6.39% |
|
+10.43% | +29.73% |
| Market Cap | 40.34B 421M 370M 348M 318M 594M 599M 4.18B 1.62B 20.58B 1.58B 1.55B 66.7B | P/E 2025 |
35.6x | P/E 2026 | 8.19x |
|---|---|---|---|---|---|
| Enterprise Value | 42.45B 443M 389M 366M 335M 625M 630M 4.4B 1.7B 21.65B 1.66B 1.63B 70.18B | EV / Sales 2025 |
2.49x | EV / Sales 2026 | 1.03x |
| Free-Float |
28.74% | Yield 2025 * |
-
| Yield 2026 | - |
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| UNICHEMLAB | Delayed | |
NSE India S.E.
| UNICHEMLAB | Delayed |
| 1 day | +6.39% | ||
| 1 week | +10.43% | ||
| Current month | +2.99% | ||
| 1 month | +8.94% | ||
| 3 months | +27.99% | ||
| 6 months | +82.93% | ||
| Current year | +29.73% |
| 1 week | 521.2 |  | 576 |
| 1 month | 497.8 | | 591.25 |
| Current year | 278.2 | | 687.2 |
| 1 year | 278.2 | | 687.2 |
| 3 years | 278.2 | | 937.95 |
| 5 years | 198 | | 937.95 |
| 10 years | 80 | | 937.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 2023-08-09 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 2024-08-07 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 1977-08-21 | |
Pranay Godha
BRD | Director/Board Member | 53 | 2023-08-09 |
| Director/Board Member | 57 | 2023-08-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.39% | +10.43% | - | - | 394M | |
| -1.64% | +1.31% | +52.46% | +109.07% | 1,043B | |
| -0.01% | +0.74% | +54.51% | +67.71% | 649B | |
| -0.05% | +0.78% | +19.09% | +73.55% | 469B | |
| -0.25% | +0.72% | +33.97% | +45.63% | 355B | |
| +0.98% | +3.30% | +19.63% | +27.91% | 270B | |
| -1.91% | +2.59% | +8.09% | +12.53% | 262B | |
| -1.01% | +8.10% | +41.99% | +51.70% | 222B | |
| -0.85% | +3.47% | +34.56% | +101.80% | 189B | |
| -2.53% | -8.57% | -34.17% | -60.67% | 175B | |
| Average | +0.20% | +2.20% | +25.57% | +47.69% | 403.67B | |
| Weighted average by Cap. | -0.05% | +2.19% | +35.33% | +65.85% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 21.11B 221M 194M 182M 167M 311M 313M 2.19B 847M 10.77B 828M 810M 34.9B | 22.02B 230M 202M 190M 174M 324M 327M 2.28B 883M 11.23B 864M 845M 36.41B |
| Net income | 1.38B 14.37M 12.62M 11.85M 10.85M 20.26M 20.41M 142M 55.16M 701M 53.94M 52.76M 2.27B | 2.53B 26.41M 23.2M 21.79M 19.94M 37.26M 37.52M 262M 101M 1.29B 99.18M 97.01M 4.18B |
| Net Debt | 3.7B 38.67M 33.96M 31.9M 29.2M 54.55M 54.94M 383M 148M 1.89B 145M 142M 6.12B | 2.11B 22.01M 19.33M 18.16M 16.62M 31.04M 31.26M 218M 84.5M 1.07B 82.64M 80.83M 3.48B |
Employees
2,780
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-23 | ₹573.20 | +6.39% | 294,887 |
| 26-09-22 | ₹538.75 | -0.35% | 114,861 |
| 26-09-21 | ₹540.65 | -0.93% | 72,661 |
| 26-09-18 | ₹545.70 | +1.35% | 26,772 |
| 26-09-17 | ₹538.45 | +2.71% | 82,024 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
